Technical Analysis for PRQR - ProQR Therapeutics B.V.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Upper Bollinger Band Walk | Strength | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Pocket Pivot | Bullish Swing Setup | -3.52% | |
Wide Range Bar | Range Expansion | -3.52% | |
Upper Bollinger Band Walk | Strength | -3.52% | |
Wide Bands | Range Expansion | -3.52% | |
Above Upper BB | Strength | -3.52% |
Alert | Time |
---|---|
Possible Inside Day | about 9 hours ago |
Down 5% | about 13 hours ago |
Down 3% | about 13 hours ago |
Down 2 % | about 13 hours ago |
Down 1% | about 13 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/27/2024
ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Genetic Disorder Alnylam Pharmaceuticals Therapeutic Gene Modulation Treatment Of Cystic Fibrosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Genetic Disorder Alnylam Pharmaceuticals Therapeutic Gene Modulation Treatment Of Cystic Fibrosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.85 |
52 Week Low | 1.11 |
Average Volume | 348,401 |
200-Day Moving Average | 1.72 |
50-Day Moving Average | 2.10 |
20-Day Moving Average | 2.08 |
10-Day Moving Average | 2.16 |
Average True Range | 0.19 |
RSI (14) | 66.22 |
ADX | 19.28 |
+DI | 31.48 |
-DI | 10.88 |
Chandelier Exit (Long, 3 ATRs) | 2.14 |
Chandelier Exit (Short, 3 ATRs) | 2.39 |
Upper Bollinger Bands | 2.45 |
Lower Bollinger Band | 1.71 |
Percent B (%b) | 1.02 |
BandWidth | 35.98 |
MACD Line | 0.09 |
MACD Signal Line | 0.02 |
MACD Histogram | 0.062 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.72 | ||||
Resistance 3 (R3) | 2.73 | 2.65 | 2.68 | ||
Resistance 2 (R2) | 2.65 | 2.58 | 2.65 | 2.67 | |
Resistance 1 (R1) | 2.56 | 2.54 | 2.52 | 2.55 | 2.65 |
Pivot Point | 2.48 | 2.48 | 2.46 | 2.48 | 2.48 |
Support 1 (S1) | 2.39 | 2.42 | 2.35 | 2.39 | 2.29 |
Support 2 (S2) | 2.31 | 2.38 | 2.31 | 2.27 | |
Support 3 (S3) | 2.22 | 2.31 | 2.26 | ||
Support 4 (S4) | 2.22 |